Technetium-99m hexamethyl propylene amine oxime-labeled leukocyte scintigraphy at three different times in active ulcerative colitis: Comparison with colonoscopy and clinico-biochemical parameters in the assessment of disease extension and severity

Annals of Nuclear Medicine

Volumn 22, Issue 5, 2008, Pages 371-377

  Aydin, Funda ^a   Dinçer, Dinç ^a   Güngör, Firat ^a   Boz, Adil ^a   Akça, Serdar ^a   Yildiz, Akin ^a   Tosun, Özgür ^a   Karayalçin, Binnur ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Colonoscopy; Imaging time; Tc 99m HMPAO; Ulcerative colitis

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLONOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY TEST; LEUKOCYTE; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKOCYTES; MALE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M EXAMETAZIME;

EID: 46649109934     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0131-6     Document Type: Article

References (35)

1. Hanauer SB. Drug therapy: inflammatory bowel disease. N Engl J Med 1996;334:841.
2. Lantto E, Jarvi K, Krekela I, Lantto T, Taavitsainen M, Vedenkangas H, et al. Technetium-99m HMPAO leukocytes in the assessment of disease activity in IBD. Eur J Nucl Med 1992;19:14-18.
3. Charron M. Inflammatory bowel disease activity assessment with biologic markers and 99mTc-WBC scintigraphy: are there different trends in ileitis versus colitis? J Nucl Med 2003;44:1586-1591.
4. Delgado M, Garcia M, Escalera T, Prats E, Abós MD, Banzo J. Aportación de la gammagrafia con leucocitos 99mTc-HMPAO en el diagnóstico del megacolon tóxico. Rev Esp Med Nucl 1992;11:19-21.
5. Saverymuttu SH, Peters AM, Hodgson HJ, Chadwick VS, Lavender JP. Indium-111 autologous leucocyte scanning: comparison with radiology for imaging the colon in inflammatory bowel disease. Br Med J 1982;285:255-257.
6. Buxton Thomas MS, Dickinson RJ, Maltby P, Hunter JO, Wraight EP. Evaluation of indium scintigraphy in patients with active inflammatory bowel disease. Gut 1984;25:1372-1375.
7. Allan RA, Sladen GE, Bassingham S, Lazarus C, Clarke SE, Fogelman I. Comparison of simultaneous 99mTc-HMPAO and 111 In oxine labelled white cell scans in the assessment of inflammatory bowel disease. Eur J Nucl Med 1993;20:195-200.
8. Gibson P, Lichtenstein M, Salehi N, Hebbard G, Andrews J. Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation. Gut 1991;32:1502-1507.
9. Scholmerich J, Schmidt E, Schumichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leucocyte label. Gastroenterology 1988;95:1287-1293.
10. Giaffer MH, Tindale WB, Holdsworth D. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:1195-1200.
11. Guimbaud R, Beades E, Chauvelot-Moachon L, Quartier G, Gauric M, Bertrand V, et al. Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic and pathologic intensity and local release of interleukin 8. Gastrointest Endosc 1998;48:491-496.
12. Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. Gut 1993;34:1364-1369.
13. Martin-Comin J, Prats E. Clinical applications of radiolabeled blood elements in inflammatory bowel disease. Q J Nucl Med 1999;43:74-82.
14. Giaffer MH, Tindale WB, Senior S, Barber DC, Holdsworth CD. Quantification of disease activity in Chron's disease by computer analysis of Tc-99m hexamethyl propylene amine oxime (HMPAO) labelled leucocyte images. Gut 1993;34:68-74.
15. Jewell FM, Davies A, Sandhu B, Duncan A, Grier D. Technetium-99m-HMPAO labelled leucocytes in the detection and monitoring of inflammatory bowel disease in children. Br J Radiol 1996;69:508-514.
16. Arndt JW, Grootscholten MI, van Hogezand RA, Griffioen G, Lamers CB, Pauwels EK. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes. Dig Dis Sci 1997;42:387-393.
17. Roddie ME, Peters AM, Danpure HJ, Osman S, Henderson BL, Lavender JP, et al. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. Radiology 1988;166:767-772.
18. Papos M, Nagy F, Lang J, Csernay L. Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease. Eur J Nucl Med 1993;20:766-769.
19. Almer S, Franzen L, Peters AM, Tjadermo M, Ekberg S, Granerus G, et al. Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis? Scand J Gastroenterol 1992;27:1031-1038.
20. Sans M, Fuster D, Llach J, Lomena F, Bordas JM, Herranz R, et al. Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease. Dig Dis Sci 2000;9:1828-1835.
21. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ 1955;2:1041-1048.
22. Hanauer S. Inflammatory bowel disease. N Eng J Med 1996;334:841-848.
23. Kornbluth A, Sachar DB. Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004;99:1371-1385.
24. Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986;27:92-95.
25. Roca M, Martin-Comin J, Becker W, Bernardo-Filho M, Gutfilen B, Moisan A, et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1998;25:797-799.
26. Bennink R, Peeters M, D'haens G, Rutgeerts P, Mortelmans L. Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of ulcerative colitis. Clin Nucl Med 2001;26:99-104.
27. Ybern A, Martin-Comin J, Gine JJ, Casanovas T, Villa R, Gassul MA. 111In-oxine-labelled autologous leucocytes in inflammatory bowel disease: new scintigraphic activity index. Eur J Nucl Med 1986;11:341-344.
28. Stein DT, Gray GM, Gregory PB, Malcom A, Goodwin DA, McDougall IR. Location and activity of ulcerative and Crohn's colitis by 111-In leukocyte scan. Gastroenterology 1984;84:388-393.
29. Giaffer MH. Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications. Gut 1996;38:1-5.
30. Louis E, Ancion G, Colard A, Spote V, Belaiche J, Hustinx R. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med 2007;48:1053-1059.
31. Meisner RS, Spier BJ, Einarsson S, Roberson EN, Perlman SB, Bianco JA, et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:993-1000.
32. Pill SG, Parvizi J, Tang PH, Garino JP, Nelson C, Zhuang H, et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty 2006;21:91-97.
33. Dumarey N, Egrise D, Blocklet D, Stallenberg B, Remmelink M, del Marmol V, et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 2006;47:625-632.
34. Rini JN, Bhargava KK, Tronco GG, Singer C, Caprioli R, Marwin SE, et al. PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection. Radiology 2006;238:978-987.
35. Pio BS, Byrne FR, Aranda R, Boulay G, Spicher K, Song MH, et al. Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-d-glucose-labeled white blood cells. Mol Imaging Biol 2003;5:271-277.